Stay updated on Oral QLT091001 in LCA/RP Due to RPE65/LRAT Mutations Clinical Trial
Sign up to get notified when there's something new on the Oral QLT091001 in LCA/RP Due to RPE65/LRAT Mutations Clinical Trial page.

Latest updates to the Oral QLT091001 in LCA/RP Due to RPE65/LRAT Mutations Clinical Trial page
- Check6 days agoChange DetectedThe page revision tag was updated from v3.6.0 to v3.6.3, indicating a newer version of the page content. This update acts as an internal version-control marker rather than a substantive change to the study information.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedA recruitment status message 'No longer looking for participants' appears, signaling that enrollment is closed. New user guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) have been added and the page revision tag updated to Revision: v3.6.0.SummaryDifference0.6%

- Check28 days agoChange DetectedRevision tag on the page updated from v3.5.4 to v3.5.5, signaling a newer page version. This reflects an internal page revision and does not alter the study content or displayed information.SummaryDifference0.1%

- Check49 days agoChange DetectedA new revision tag v3.5.4 has been added and the previous v3.5.3 tag removed. This represents a minor metadata update to the study record without changing its substantive content.SummaryDifference0.1%

- Check56 days agoChange DetectedNo additions or deletions are present in the analyzed changes payload for this page. This indicates that the page content has not been altered in the provided data.SummaryDifference0.1%

- Check71 days agoChange DetectedThe page’s footer version label updates from “Revision: v3.5.2” to “Revision: v3.5.3,” indicating a minor site release without changing the study record content.SummaryDifference0.1%

Stay in the know with updates to Oral QLT091001 in LCA/RP Due to RPE65/LRAT Mutations Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral QLT091001 in LCA/RP Due to RPE65/LRAT Mutations Clinical Trial page.